metaPreg - Oxprenolol (versus unexposed) during pregnancy

Oxprenolol (versus unexposed) updated on 12-17-2024

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
Cleft lip with or without cleft palate	4.20 [1.78, 9.90]	-	1 study	1,374	47	not evaluable	ROB	7.87 [2.96; .]
Cleft palate	3.60 [1.10, 11.74]	-	1 study	601	53	not evaluable	ROB	6.66 [1.44; .]
Neural Tube Defects	1.40 [0.20, 9.90]	-	1 study	1,202	24	not evaluable	ROB	-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	1.52 [0.64, 3.62]	-	1 study	26	50	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Low Apgar score (< 7) (at 5 min)	0.63 [0.06, 6.24]	-	1 study	4	49	not evaluable	ROB	-
Neonatal bradycardia	2.22 [1.09, 4.51]	-	1 study	53	49	not evaluable	ROB	3.86 [1.41; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine death (< 22 weeks)	5.91 [0.24, 147.74]	-	1 study	1	50	not evaluable	ROB	-
Late intrauterine deaths (> 22 weeks)	0.38 [0.02, 8.02]	-	1 study	2	50	not evaluable	ROB	-
Hide endpoints reported in only one study ...